Introduction Thalassemia is a genetic blood disorder that affects hemoglobin production, and it often shows no obvious symptoms in the earliest months of life. That’s why thalassemia screening in infants is essential. Early detection can prevent severe anemia, organ damage, and complications that may develop if the condition goes unnoticed. Newborns and infants are particularly vulnerable because their immune systems are still developing, making timely screening critical for proactive healthcare. Through HPLC (High-Performance Liquid Chromatography) testing , doctors can detect both major and minor forms of thalassemia. Early awareness helps families plan treatment, monitor hemoglobin levels, and take preventive measures to maintain the child’s overall well-being. What Is Thalassemia Screening in Infants? Thalassemia screening in infants is a specialized blood test aimed at identifying genetic hemoglobin disorders at the earliest possible stage. HPLC testing is one of the most ...